Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue Carcinoma

被引:45
作者
Hori Y. [1 ]
Kubota A. [1 ]
Yokose T. [2 ]
Furukawa M. [1 ]
Matsushita T. [1 ]
Takita M. [3 ]
Mitsunaga S. [4 ]
Mizoguchi N. [5 ]
Nonaka T. [5 ]
Nakayama Y. [5 ]
Oridate N. [6 ]
机构
[1] Department of Head and Neck Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa
[2] Department of Pathology, Kanagawa Cancer Center, Yokohama, Kanagawa
[3] Department of Clinical Trial Management, Kanagawa Cancer Center, Yokohama, Kanagawa
[4] Department of Oral Maxillofacial Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa
[5] Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa
[6] Department of Otolaryngology Head and Neck Surgery, Yokohama City University, Yokohama, Kanagawa
基金
日本学术振兴会;
关键词
Depth of tumor; Early tongue carcinoma; Lymph node metastasis; Squamous cell carcinoma; Tumor budding;
D O I
10.1007/s12105-017-0814-1
中图分类号
学科分类号
摘要
In clinical N0 early oral tongue carcinoma, treatment of occult lymph node metastasis is controversial. The purpose of this study was to assess the histopathological risk factors for predicting late lymph node metastasis in early oral tongue carcinoma. We retrospectively reviewed 48 patients with early oral tongue squamous cell carcinoma. Associations between the histopathological factors (depth of tumor, differentiation, blood vessel invasion, lymphatic invasion, and tumor budding) and late lymph metastasis were analyzed. Although the univariate analysis identified blood vessel invasion, lymphatic invasion, and high-grade tumor budding as predictive factors for neck recurrence (p < 0.001), the Cox proportional hazards model identified high-grade tumor budding as an independent predictive factor (p < 0.01). The combination of a tumor depth ≥ 3 mm and high-grade tumor budding yielded high diagnostic accuracy. Tumor depth and budding grade were identified as histopathological risk factors for late neck recurrence in clinical N0 early oral tongue carcinoma. © 2017, Springer Science+Business Media New York.
引用
收藏
页码:477 / 486
页数:9
相关论文
共 37 条
[1]  
D'Cruz A.K., Vaish R., Kapre N., Et al., Elective versus therapeutic neck dissection in node-negative oral cancer, N Engl J Med, 373, (2015)
[2]  
Yuen A.P., Wei W.I., Wong Y.M., Tang K.C., Elective neck dissection versus observation in the treatment of early oral tongue carcinoma, Head Neck, 19, 7, pp. 583-588, (1997)
[3]  
Lim Y.C., Lee J.S., Koo B.S., Kim S.H., Kim Y.H., Choi E.C., Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation, Laryngoscope, 116, 3, pp. 461-465, (2006)
[4]  
Kelner N., Vartanian J.G., Pinto C.A., Coutinho-Camillo C.M., Kowalski L.P., Does elective neck dissection in T1/T2 carcinoma of the oral tongue and floor of the mouth influence recurrence and survival rates?, Br J Oral Maxillofac Surg, 52, 7, pp. 590-597, (2014)
[5]  
Broglie M.A., Haerle S.K., Huber G.F., Haile S.R., Stoeckli S.J., Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival, Head Neck, 35, 5, pp. 660-666, (2013)
[6]  
Huang S.H., Hwang D., Lockwood G., Goldstein D.P., O'Sullivan B., Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies, Cancer, 115, 7, pp. 1489-1497, (2009)
[7]  
Kovacs A.F., Stefenelli U., Seitz O., Et al., Positive sentinel lymph nodes are a negative prognostic factor for survival in T1-2 oral/oropharyngeal cancer-a long-term study on 103 patients, Ann Surg Oncol, 16, 2, pp. 233-239, (2009)
[8]  
Govers T.M., Hannink G., Merkx M.A., Takes R.P., Rovers M.M., Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis, Oral Oncol, 49, 8, pp. 726-732, (2013)
[9]  
Alkureishi L.W., Ross G.L., Shoaib T., Et al., Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial, Ann Surg Oncol, 17, 9, pp. 2459-2464, (2010)
[10]  
Bosman F.T.C.F., Hruban R.H., Theise N.D., WHO classification of tumours of the digestive system, pp. 134-146, (2010)